NervGen Pharma Corp.
NGENF · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$24,006 | -$22,382 | -$20,722 | -$12,727 |
| Dep. & Amort. | $84 | $145 | $115 | $43 |
| Deferred Tax | $0 | $0 | -$2,596 | $0 |
| Stock-Based Comp. | $5,796 | $6,045 | $2,775 | $4,016 |
| Change in WC | $839 | -$240 | $2,115 | $430 |
| Other Non-Cash | $447 | $5,137 | $529 | -$31 |
| Operating Cash Flow | -$16,841 | -$11,296 | -$17,784 | -$8,269 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | -$6 | -$21 | -$45 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $0 | $0 | $0 |
| Other Inv. Act. | $59 | -$133 | $0 | -$0 |
| Investing Cash Flow | $59 | -$139 | -$21 | -$45 |
| Financing Activities | – | – | – | – |
| Debt Repay. | -$101 | -$101 | -$76 | $0 |
| Stock Issued | $23,012 | $867 | $19,763 | $18,902 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$216 | $867 | $2,954 | $712 |
| Financing Cash Flow | $22,695 | $766 | $22,641 | $19,613 |
| Forex Effect | -$305 | -$124 | $687 | $31 |
| Net Chg. in Cash | $5,608 | -$10,792 | $5,523 | $11,330 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $11,660 | $22,452 | $16,929 | $5,599 |
| End Cash | $17,267 | $11,660 | $22,452 | $16,929 |
| Free Cash Flow | -$16,841 | -$11,437 | -$17,805 | -$8,314 |